Alps Advisors Inc Mirum Pharmaceuticals, Inc. Transaction History
Alps Advisors Inc
- $15.7 Billion
- Q4 2024
A detailed history of Alps Advisors Inc transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Alps Advisors Inc holds 38,822 shares of MIRM stock, worth $1.79 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
38,822
Previous 37,245
4.23%
Holding current value
$1.79 Million
Previous $1.45 Million
10.54%
% of portfolio
0.01%
Previous 0.01%
Shares
10 transactions
Others Institutions Holding MIRM
# of Institutions
210Shares Held
53.7MCall Options Held
2.6KPut Options Held
99.7K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.57MShares$302 Million16.29% of portfolio
-
Janus Henderson Group PLC London, X04.58MShares$211 Million0.1% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$149 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA2.8MShares$129 Million4.33% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.61MShares$120 Million2.07% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.69B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...